About Susan Whoriskey
Susan Whoriskey is a director at Ratio Therapeutics.
Susan Whoriskey first appears on SEC filings in 2023.
Experience
This experience comes from Susan Whoriskey's profile and from SEC filings. For roles taken from filings, the years are when the filings name Susan Whoriskey in the role, so the role may have started earlier or lasted longer.
Ratio Therapeutics, Inc. Current
Board of Directors & Strategic Advisor
2022 – Present · Boston, MA
Develops targeted radioactive medicines for people with cancer.
VI
Vera Therapeutics, Inc. Current
Founding Executive Team, Chief Technology Strategy
2015 – Present
MO
Moderna
Founding Executive Team, Senior Vice President Technology Strategy
2011 – 2014
MI
MIT
Entrepreneur in Residence-Life Sciences
2009 – 2010
MP
Momenta Pharmaceuticals
Founding Executive Team, Head Technology Strategy & Corporate Development
2002 – 2007
PP
Polaris Partners
Entrepreneur in Residence
2001 – 2002
CP
Cubist Pharmaceuticals
Founding Executive Team, Scientific Licensing & Business Development
1993 – 2001
Key Colleagues at Startups
The people Susan Whoriskey works with at each company, as listed on that company's latest Form D.
Ratio Therapeutics, Inc. · Form D, Jul 31, 2026
SM
Scott MacDonald
Executive officer
MB
Marc Becker
Chief Financial Officer and Chief Operating Officer
AH
Albert Holman
Director
BI
Brandon Ingersoll
Director
AG
Allan Green
Director
WC
William Cowan
Director
JH
John Hoppin
Chief Executive Officer and director
JB
John Babich
Chief Scientific Officer and director